To identify risk factors for human immunodeficiency virus (HIV) infection in intravenous drug users, we undertook a study of the seroprevalence of HIV antibody in 452 persons enrolled in a methadone-treatment program in the Bronx, New York. The seroprevalence of HIV was 39.4 percent overall, 49.1 percent in blacks, 41.8 percent in Hispanics, and 17.2 percent in non-Hispanic whites (P less than 0.001 for all comparisons). The presence of HIV antibody was associated with the number of injections per month (P less than 0.001), the percentage of injections with used needles (P less than 0.001), the average number of injections with cocaine per month (P less than 0.001), and the percentage of injections with needles that were shared with strangers or acquaintances (P less than 0.001), a practice that was more common among blacks and Hispanics than among whites. The number of heterosexual sex partners who used intravenous drugs was associated with HIV infection in women (P less than 0.004) and was the only risk factor found for users who had not injected drugs after 1982 (P less than 0.05). The presence of HIV antibody was independently associated with being black or Hispanic (adjusted odds ratio, 4.56; 95 percent confidence interval, 2.65 to 8.14), a more recent year of the last injection of drugs (adjusted odds ratio, 1.24; 95 percent confidence interval, 1.13 to 1.35), the percentage of injections of drugs that took place in "shooting galleries" (adjusted odds ratio, 1.49; 95 percent confidence interval, 1.19 to 1.88), having sex partners who used intravenous drugs (adjusted odds ratio 1.24; 95 percent confidence interval, 1.06 to 1.45), and low income (adjusted odds ratio, 1.55; 95 percent confidence interval, 1.10 to 2.17). We conclude that differences in both the social setting of drug use and behavior related to injection carry different risks for infection with HIV and may explain, in part, the higher seroprevalence of HIV among blacks and Hispanics. In addition, we found that heterosexual activity was an independent risk factor for drug users.
Source Information
Department of Epidemiology and Social Medicine, Montefiore Medical Center, Bronx, NY 10467.
This article has been cited by other articles:
Romero, E. G., Teplin, L. A., McClelland, G. M., Abram, K. M., Welty, L. J., Washburn, J. J.
(2007). A Longitudinal Study of the Prevalence, Development, and Persistence of HIV/Sexually Transmitted Infection Risk Behaviors in Delinquent Youth: Implications for Health Care in the Community. Pediatrics
119: e1126-e1141
[Abstract][Full Text]
Fuller, C. M., Borrell, L. N., Latkin, C. A., Galea, S., Ompad, D. C., Strathdee, S. A., Vlahov, D.
(2005). Effects of Race, Neighborhood, and Social Network on Age at Initiation of Injection Drug Use. Am. J. Public Health
95: 689-695
[Abstract][Full Text]
Nelson, K. E., Galai, N., Safaeian, M., Strathdee, S. A., Celentano, D. D., Vlahov, D.
(2002). Temporal Trends in the Incidence of Human Immunodeficiency Virus Infection and Risk Behavior among Injection Drug Users in Baltimore, Maryland, 1988-1998. Am J Epidemiol
156: 641-653
[Abstract][Full Text]
McClelland, G. M., Teplin, L. A., Abram, K. M., Jacobs, N.
(2002). HIV and AIDS Risk Behaviors Among Female Jail Detainees: Implications for Public Health Policy. Am. J. Public Health
92: 818-825
[Abstract][Full Text]
Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., Nelson, K. E.
(2001). Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective. Arch Intern Med
161: 1281-1288
[Abstract][Full Text]
Bruneau, J., Lamothe, F., Soto, J., Lachance, N., Vincelette, J., Vassal, A., Franco, E. L.
(2001). Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ
164: 767-773
[Abstract][Full Text]
Zaric, G. S., Brandeau, M. L., Barnett, P. G.
(2000). Methadone Maintenance and HIV Prevention: A Cost-Effectiveness Analysis. Management Science
46: 1013-1031
[Abstract]
Estebanez, P. E, Russell, N. K, Aguilar, M D., Beland, F., Zunzunegui, M. V., Study Group on Risk Behaviour in Female Injecting, t.
(2000). Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol
29: 734-743
[Abstract][Full Text]
Berger, A. R., Schaumburg, H. H., Gourevitch, M. N., Freeman, K., Herskovitz, S., Arezzo, J. C.
(1999). Prevalence of peripheral neuropathy in injection drug users. Neurology
53: 592-592
[Abstract][Full Text]
Mello, N. K., Negus, S. S.
(1998). The Effects of Buprenorphine on Self-administration of Cocaine and Heroin "Speedball" Combinations and Heroin Alone by Rhesus Monkeys. J. Pharmacol. Exp. Ther.
285: 444-456
[Abstract][Full Text]
Owens, D. K., Brandeau, M. L., Sox, C. H.
(1998). Effect of Relapse to High-Risk Behavior on the Costs and Benefits of a Program to Screen Women for Human Immunodeficiency Virus. Interfaces
28: 52-74
[Abstract]
Mendelson, J. H., Mello, N. K.
(1996). Management of Cocaine Abuse and Dependence. NEJM
334: 965-972
[Full Text]
Longshore, D.
(1996). Prevalence and Circumstances of Drug Injection at Los Angeles Shooting Galleries. Crime Delinquency
42: 21-35
[Abstract]
Farrell, M, Ward, J, Mattick, R, Hall, W, Stimson, G V, des Jarlais, D, Gossop, M, Strang, J
(1994). Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review. BMJ
309: 997-1001
[Full Text]
O'Connor, P. G., Selwyn, P. A., Schottenfeld, R. S.
(1994). Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection. NEJM
331: 450-459
[Full Text]
Previous
